Cite
HARVARD Citation
Akizawa, T. et al. (2022). Two long‐term phase 3 studies of enarodustat (JTZ‐951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND‐Long and HD‐Long studies. Therapeutic apheresis and dialysis. 26 (2), pp. 345-356. [Online].